Abstract
BackgroundTo systematically investigate the current status and methodology of health technology reassessment (HTR) in various countries to draw insights for the healthcare system in South Korea.MethodsA systematic literature search was conducted on the articles published between January 2000 and February 2015 on Medline, EMBASE, the Cochrane Library, CINAHL, and PubMed. The titles and abstracts of retrieved records were screened and selected by two independent reviewers. Data related to HTR were extracted using a pre-standardised form. The review was conducted using narrative synthesis to understand and summarise the HTR process and policies.ResultsForty five studies, conducted in seven countries, including the United Kingdom, Australia, Canada, Spain, Sweden, Denmark, and the United States of America, fulfilled the inclusion criteria. Informed by the literature review, and complemented by informant interviews, we focused on HTR activities in four jurisdictions: the United Kingdom, Canada, Australia, and Spain. There were similarities in the HTR processes, namely the use of existing health technology assessment agencies, reassessment candidate technology identification and priority setting, stakeholder involvement, support for reimbursement coverage, and implementation strategies. Considering the findings of the systematic review in the context of the domestic healthcare environment in Korea, an appropriate HTR model was developed. This model included four stages, those of identification, prioritisation, reassessment and decision.ConclusionsDisinvestment and reinvestment through the HTR was used to increase the efficiency and quality of care to help patients receive optimal treatment. Based on the lessons learnt from other countries’ experiences, Korea should make efforts to establish an HTR process that optimises the National Healthcare Insurance system through revision of the existing Medical Service Act.
Highlights
To systematically investigate the current status and methodology of health technology reassessment (HTR) in various countries to draw insights for the healthcare system in South Korea
In the 2012 Health Policy Forum of Health Technology Assessment International [3], health technology reassessment (HTR) was proposed as an integral part of health technology assessment (HTA) agencies in order to enhance the optimal use of health technologies and to ensure value for money
Studies included The electronic database and grey literature search, including the Health Technology Assessment International (HTAi) and INAHTA websites, yielded 20,395 records, of which the full text of 8045 articles were read after excluding duplicates
Summary
To systematically investigate the current status and methodology of health technology reassessment (HTR) in various countries to draw insights for the healthcare system in South Korea. In 2010, the Center for New Health Technology Assessment was integrated into the NECA [4]. Several countries, such as the United Kingdom, Australia, Canada, and Spain, have demonstrated growing interest in HTR development and implementation. The aim of this study was to systematically review the HTR-related literature to examine (1) the organisation/ governance of HTR; (2) the process used for identifying candidate technology for reassessment and candidate technology prioritisation; (3) the stakeholder engagement, decision-making processes, and implementation strategies; and (4) the general HTR landscape to obtain insights into developing HTR in South Korea
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
